Ibio (0JV0) Financial Statements
Ibio Financial Overview
Ibio's market cap is currently $41.74M. The company's EPS TTM is $-0.33; its P/E ratio is -2.36; Ibio is estimated to report earnings on November 17, 2026, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 100.00K | $ 400.00K | $ 225.00K | $ 0.00 | $ 1.88M |
| Gross Profit | $ 100.00K | $ 400.00K | $ 225.00K | $ 0.00 | $ -1.91M |
| Operating Income | $ -35.14M | $ -18.60M | $ -16.63M | $ -29.34M | $ -29.70M |
| EBITDA | $ -31.96M | $ -17.04M | $ -14.02M | $ -27.85M | $ -25.72M |
| Net Income | $ -33.04M | $ -18.38M | $ -24.91M | $ -65.01M | $ -50.39M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 88.04M | $ 8.58M | $ 14.21M | $ 7.33M | $ 33.52M |
| Total Assets | $ 99.11M | $ 23.18M | $ 28.73M | $ 41.21M | $ 99.41M |
| Total Debt | $ 2.20M | $ 3.51M | $ 4.46M | $ 17.07M | $ 25.77M |
| Net Debt | $ -54.20M | $ -5.07M | $ -9.75M | $ 9.75M | $ 3.09M |
| Total Liabilities | $ 13.40M | $ 8.30M | $ 7.41M | $ 25.83M | $ 35.92M |
| Stockholders' Equity | $ 85.71M | $ 14.88M | $ 21.32M | $ 15.38M | $ 63.48M |
| Cash Flow | |||||
| Free Cash Flow | $ -23.80M | $ -15.32M | $ -18.76M | $ -36.17M | $ -45.13M |
| Operating Cash Flow | $ -23.22M | $ -15.30M | $ -18.55M | $ -30.44M | $ -37.80M |
| Investing Cash Flow | $ -32.00M | $ 742.00K | $ 906.00K | $ 7.01M | $ -5.13M |
| Financing Cash Flow | $ 103.05M | $ 8.93M | $ 24.49M | $ 2.30M | $ -5.80M |
Currency in USD